| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |